Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 68.18% is in line with its 5-year average of 68.76%, around the middle of its 5-year range (61.32%–73.14%).
0.16% above its 12-month average of 68.07%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 70.07%.
GROSS MARGIN
68.18%
GROSS MARGIN AVG TTM
68.07%
GROSS MARGIN AVG 3Y
68.93%
GROSS MARGIN AVG 5Y
68.76%
GROSS MARGIN AVG 10Y
67.06%
GROSS MARGIN AVG 15Y
73.48%
GROSS MARGIN AVG 20Y
76.61%
CURRENT VS TTM AVG
+0.16%
CURRENT VS 3Y AVG
-1.08%
CURRENT VS 5Y AVG
-0.84%
CURRENT VS 10Y AVG
+1.67%
CURRENT VS 15Y AVG
-7.21%
CURRENT VS 20Y AVG
-11.00%
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 729 covered companies
CURRENT VS SECTOR MEDIAN
+67.03%
vs the sector median at left
Market Cap
$4.10B
Gross Margin
76.83%
TTM Avg
-1487.68%
3Y Avg
-5412.33%
5Y Avg
-4507.64%
Market Cap
$4.12B
Gross Margin
61.64%
TTM Avg
80.82%
3Y Avg
86.99%
5Y Avg
87.36%
Market Cap
$4.36B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.36B
Gross Margin
80.08%
TTM Avg
75.94%
3Y Avg
72.82%
5Y Avg
72.82%
Market Cap
$4.41B
Gross Margin
75.44%
TTM Avg
66.98%
3Y Avg
64.58%
5Y Avg
67.25%
Market Cap
$4.42B
Gross Margin
83.86%
TTM Avg
80.36%
3Y Avg
82.01%
5Y Avg
82.83%
Market Cap
$4.60B
Gross Margin
71.27%
TTM Avg
60.67%
3Y Avg
48.49%
5Y Avg
48.49%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LivaNova PLC (LIVN) | $4.15B | 68.18% | 68.07% | 68.93% | 68.76% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.10B | 76.83% | -1487.68% | -5412.33% | -4507.64% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.12B | 61.64% | 80.82% | 86.99% | 87.36% |
| ICU Medical, Inc. (ICUI)vs › | $3.98B | 37.56% | 35.69% | 33.68% | 34.73% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | 0.00% | 0.00% | 0.00% | 0.00% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.36B | 80.08% | 75.94% | 72.82% | 72.82% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | 75.44% | 66.98% | 64.58% | 67.25% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | 83.86% | 80.36% | 82.01% | 82.83% |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 71.27% | 60.67% | 48.49% | 48.49% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 18.17% | 19.16% | 20.78% | 21.38% |
Gross Margin
68.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 70.07% |
| 2026-03-31 | 67.59% |
| 2025-12-31 | 66.45% |
| 2025-09-30 | 68.45% |
| 2025-06-30 | 67.79% |
| 2025-03-31 | 69.68% |
| 2024-12-31 | 68.16% |
| 2024-09-30 | 70.81% |
| 2024-06-30 | 67.45% |
| 2024-03-31 | 70.32% |
| 2023-12-31 | 61.32% |
| 2023-09-30 | 70.53% |
| 2023-06-30 | 69.82% |
| 2023-03-31 | 66.09% |
| 2022-12-31 | 66.76% |
| 2022-09-30 | 67.66% |
| 2022-06-30 | 72.54% |
| 2022-03-31 | 70.13% |
| 2021-12-31 | 73.14% |
| 2021-09-30 | 66.61% |
| 2021-06-30 | 65.14% |
| 2021-03-31 | 66.00% |
| 2020-12-31 | 56.08% |
| 2020-09-30 | 59.48% |
| 2020-06-30 | 63.93% |
| 2020-03-31 | 70.35% |
| 2019-12-31 | 71.16% |
| 2019-09-30 | 66.79% |
| 2019-06-30 | 71.12% |
| 2019-03-31 | 65.23% |
| 2018-12-31 | 68.72% |
| 2018-09-30 | 64.08% |
| 2018-06-30 | 67.48% |
| 2018-03-31 | 64.74% |
| 2017-12-31 | 61.82% |
| 2017-09-30 | 64.52% |
| 2017-06-30 | 65.58% |
| 2017-03-31 | 64.69% |
| 2016-12-31 | 52.80% |
| 2016-09-30 | 63.95% |
| 2016-06-30 | 59.28% |
| 2016-03-31 | 56.93% |
| 2015-12-31 | 0.00% |
| 2015-10-18 | 85.88% |
| 2015-09-30 | 88.36% |
| 2015-04-30 | 89.75% |
| 2015-01-31 | 90.93% |
| 2014-10-31 | 90.78% |
| 2014-07-31 | 91.10% |
| 2014-04-30 | 90.08% |
| 2014-01-31 | 90.53% |
| 2013-10-31 | 90.12% |
| 2013-07-31 | 90.50% |
| 2013-04-30 | 90.70% |
| 2013-01-31 | 91.44% |
| 2012-10-31 | 91.79% |
| 2012-07-31 | 91.69% |
| 2012-04-30 | 92.23% |
| 2012-01-31 | 92.48% |
| 2011-10-31 | 92.25% |
| 2011-07-31 | 86.86% |
| 2011-04-30 | 87.87% |
| 2011-01-31 | 87.67% |
| 2010-10-31 | 88.30% |
| 2010-07-31 | 87.81% |
| 2010-04-30 | 88.48% |
| 2010-01-31 | 87.87% |
| 2009-10-31 | 87.43% |
| 2009-07-31 | 86.13% |
| 2009-04-30 | 86.75% |
| 2009-01-31 | 86.01% |
| 2008-10-31 | 85.63% |
| 2008-07-31 | 85.72% |
| 2008-04-30 | 82.61% |
| 2008-01-31 | 82.70% |
| 2007-10-31 | 84.19% |
| 2007-07-31 | 80.91% |
| 2007-04-30 | 81.78% |
| 2007-01-31 | 84.44% |
| 2006-10-31 | 88.86% |
| 2006-07-31 | 88.73% |
| 2006-04-30 | 87.79% |
| 2006-01-31 | 87.64% |
| 2005-10-31 | 86.96% |
| 2005-07-31 | 86.08% |
| 2005-04-30 | 87.56% |
| 2005-01-31 | 85.68% |
| 2004-10-31 | 85.36% |
| 2004-07-31 | 80.98% |
| 2004-04-30 | 86.35% |
| 2004-01-31 | 84.69% |
| 2003-10-31 | 85.13% |
| 2003-07-31 | 85.03% |
| 2003-04-30 | 85.15% |
| 2003-01-31 | 84.86% |
| 2002-10-31 | 85.36% |
